Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 4
2009 5
2010 2
2011 2
2012 6
2013 2
2014 3
2015 6
2016 4
2017 9
2018 5
2019 2
2020 10
2021 23
2022 12
2023 14
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
Berger G, Knelson EH, Jimenez-Macias JL, Nowicki MO, Han S, Panagioti E, Lizotte PH, Adu-Berchie K, Stafford A, Dimitrakakis N, Zhou L, Chiocca EA, Mooney DJ, Barbie DA, Lawler SE. Berger G, et al. Among authors: zhou l. Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2111003119. doi: 10.1073/pnas.2111003119. Epub 2022 Jul 5. Proc Natl Acad Sci U S A. 2022. PMID: 35787058 Free PMC article.
Therapeutic targeting of TRAIL death receptors.
Di Cristofano F, George A, Tajiknia V, Ghandali M, Wu L, Zhang Y, Srinivasan P, Strandberg J, Hahn M, Sanchez Sevilla Uruchurtu A, Seyhan AA, Carneiro BA, Zhou L, Huntington KE, El-Deiry WS. Di Cristofano F, et al. Among authors: zhou l. Biochem Soc Trans. 2023 Feb 27;51(1):57-70. doi: 10.1042/BST20220098. Biochem Soc Trans. 2023. PMID: 36629496 Free PMC article. Review.
Targeting the Integrated Stress Response in Cancer Therapy.
Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L, Zhang Y, El-Deiry WS. Tian X, et al. Among authors: zhou l. Front Pharmacol. 2021 Sep 24;12:747837. doi: 10.3389/fphar.2021.747837. eCollection 2021. Front Pharmacol. 2021. PMID: 34630117 Free PMC article. Review.
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, Carneiro B, Raufi A, Huntington K, Carlsen L, Louie A, Safran H, Seyhan AA, Tarapore RS, Schalop L, Stogniew M, Allen JE, Oster W, El-Deiry WS. Prabhu VV, et al. Among authors: zhou l. Neoplasia. 2020 Dec;22(12):725-744. doi: 10.1016/j.neo.2020.09.005. Epub 2020 Oct 23. Neoplasia. 2020. PMID: 33142238 Free PMC article. Review.
Multispectral fluorescence imaging.
Zhou L, El-Deiry WS. Zhou L, et al. J Nucl Med. 2009 Oct;50(10):1563-6. doi: 10.2967/jnumed.109.063925. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759119 Free article. Review.
Circulating tumor cells: silent predictors of metastasis.
Zhou L, Dicker DT, Matthew E, El-Deiry WS, Alpaugh RK. Zhou L, et al. F1000Res. 2017 Aug 14;6:F1000 Faculty Rev-1445. doi: 10.12688/f1000research.11313.1. eCollection 2017. F1000Res. 2017. PMID: 28868131 Free PMC article. Review.
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma.
Raufi AG, Liguori NR, Carlsen L, Parker C, Hernandez Borrero L, Zhang S, Tian X, Louie A, Zhou L, Seyhan AA, El-Deiry WS. Raufi AG, et al. Among authors: zhou l. Front Pharmacol. 2021 Nov 30;12:751568. doi: 10.3389/fphar.2021.751568. eCollection 2021. Front Pharmacol. 2021. PMID: 34916936 Free PMC article. Review.
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Huntington KE, Louie AD, Srinivasan PR, Schorl C, Lu S, Silverberg D, Newhouse D, Wu Z, Zhou L, Borden BA, Giles FJ, Dooner M, Carneiro BA, El-Deiry WS. Huntington KE, et al. Among authors: zhou l. Int J Mol Sci. 2023 Jun 29;24(13):10870. doi: 10.3390/ijms241310870. Int J Mol Sci. 2023. PMID: 37446056 Free PMC article.
Discovery and clinical introduction of first-in-class imipridone ONC201.
Allen JE, Kline CL, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WS. Allen JE, et al. Among authors: zhou l. Oncotarget. 2016 Nov 8;7(45):74380-74392. doi: 10.18632/oncotarget.11814. Oncotarget. 2016. PMID: 27602582 Free PMC article. Review.
102 results